3835.2000 38.40 (1.01%)
NSE Aug 21, 2025 13:16 PM
Volume: 98,045
 

3835.20
1.01%
Prabhudas Lilladhar
PI reported subdued results because COVID largely led to higher than anticipated revenue decline (Revenue impact- Rs 1 bn, EBITDA- Rs 220 mn) coupled with lower other income (down 69% YoY). COVID related revenue loss is likely to recoup in Q1FY21. Both domestic and CSM businesses continue to do well with robust demand for key existing molecules (Bispyribac Sodium, Osheen, etc), new launches, entry into pharma value chain, new client additions and ramp up of molecules & facilities...
Number of FII/FPI investors decreased from 750 to 726 in Jun 2025 qtr
More from PI Industries Ltd.
Recommended